RECRUITING
I'm interested ...!!
Diabetes Toolkit at Discharge
The purpose of this randomized clinical trial is to implement the DM Discharge Toolkit into hospital discharge and assess the effect of the DM Discharge Toolkit on patients newly requiring insulin.
Conditions:
🦠 Diabetes Mellitus, Type 2 🦠 Insulin Dependent Diabetes
🗓️ Study Start (Actual) 10 January 2023
🗓️ Primary Completion (Estimated) 1 October 2024
✅ Study Completion (Estimated) 1 December 2024
👥 Enrollment (Estimated) 120
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Chicago, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * English speaking patients
    • * 18 years of age and older
    • * Expected survival \>90 days
    • * Need for new insulin at time of hospital discharge

    Exclusion Criteria:

    • * Patients with the inability to give informed consent
    • * Non-English speaking
    • * Not diagnosed with diabetes
    • * Not been newly prescribed insulin
Ages Eligible for Study: 18 Years to 90 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 17 November 2022
  • First Submitted that Met QC Criteria 15 December 2022
  • First Posted 23 December 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 11 March 2024
  • Last Update Posted 13 March 2024
  • Last Verified March 2024
I'm interested ...!!